BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23589792)

  • 1. Current routine practice and clinico-pathological characteristics associated with acute promyelocytic leukemia in Korea.
    Ahn S; Park JS; Jeong SH; Lee HW; Park JE; Kim MH; Kim YS; Lee HS; Park TS; You E; Rheem I; Park J; Huh JY; Kang MS; Cho SR
    Blood Res; 2013 Mar; 48(1):31-4. PubMed ID: 23589792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study.
    Avvisati G; Lo Coco F; Diverio D; Falda M; Ferrara F; Lazzarino M; Russo D; Petti MC; Mandelli F
    Blood; 1996 Aug; 88(4):1390-8. PubMed ID: 8695858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial insertion of retinoic acid receptor-alpha gene in acute promyelocytic leukemia with normal chromosomes 15 and 17.
    Hiorns LR; Min T; Swansbury GJ; Zelent A; Dyer MJ; Catovsky D
    Blood; 1994 May; 83(10):2946-51. PubMed ID: 8180390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal abnormality of acute promyelocytic leukemia other than
    Imataki O; Uemura M
    BMC Clin Pathol; 2016; 16():16. PubMed ID: 27708545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors of all-trans-retinoic acid related complications during induction therapy for acute promyelocytic leukemia.
    Jeddi R; Kacem K; Ben Neji H; Mnif S; Gouider E; Aissaoui L; Ben Amor R; Ben Lakhal R; Ben Abid H; Belhadjali Z; Meddeb B
    Hematology; 2008 Jun; 13(3):142-6. PubMed ID: 18702871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of PML/RARa transcripts in acute promyelocytic leukemia by real-time quantitative reverse transcription polymerase chain reaction].
    Lang L; Li HM; Liu H; Wang YM; Zhang XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):714-9. PubMed ID: 17708789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
    Marasca R; Zucchini P; Galimberti S; Leonardi G; Vaccari P; Donelli A; Luppi M; Petrini M; Torelli G
    Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A PML/RARA chimeric gene on chromosome 12 in a patient with acute promyelocytic leukemia (M4) associated with a new variant translocation: t(12;15;17)(q24;q24;q11).
    Bennour A; Tabka I; Youssef YB; Zaier M; Hizem S; Khelif A; Saad A; Sennana H
    Med Oncol; 2013 Mar; 30(1):409. PubMed ID: 23292868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does acute promyelocytic leukemia patient with the STAT5B/RARa fusion gene respond well to decitabine?: A case report and literature review.
    Wang L; Yan X; He J
    Medicine (Baltimore); 2020 Oct; 99(43):e22923. PubMed ID: 33120845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of STAT5b-RARA positive acute promyelocytic leukemia by Venetoclax combining with homoharringtonine, cytarabine: A case report and literature review.
    Zhang G; Song Y; Wan L; Liu K; Qiu S; Wang J; Mi Y
    Blood Sci; 2022 Apr; 4(2):93-96. PubMed ID: 35957665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up results of cytarabine-containing chemotherapy for acute promyelocytic leukemia.
    Park YH; Kim DY; Mun YC; Cho EK; Lee JH; Jo DY; Kim I; Yoon SS; Park SY; Kim B; Bang SM; Kim H; Min YJ; Park JH; Seo JJ; Moon HN; Lee MH; Kim CS; Lee WS; Chong SY; Oh D; Zang DY; Lee KH; Hyun MS; Kim HS; Kim SH; Kwon H; Kim HJ; Park KT; Bae SH; Ryoo HM; Choi JH; Ahn MJ; Yoon HJ; Nam SH; Kim BS; Seong CM
    Korean J Intern Med; 2022 Jul; 37(4):841-850. PubMed ID: 35811370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variant and masked translocations in acute promyelocytic leukemia.
    Brunel V; Lafage-Pochitaloff M; Alcalay M; Pelicci PG; Birg F
    Leuk Lymphoma; 1996 Jul; 22(3-4):221-8. PubMed ID: 8819070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute promyelocytic leukemia with isochromosome 17q and cryptic PML-RARA successfully treated with all-trans retinoic acid and arsenic trioxide.
    Shepshelovich D; Oniashvili N; Parnes D; Klein A; Muchtar E; Yeshaya J; Aviram A; Rabizadeh E; Raanani P
    Cancer Genet; 2015 Nov; 208(11):575-9. PubMed ID: 26471811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZBTB16-RARα-Positive Atypical Promyelocytic Leukemia: A Case Report.
    Pardo Gambarte L; Franganillo Suárez A; Cornago Navascués J; Soto de Ozaeta C; Blas López C; Atance Pasarisas M; Salgado Sánchez RN; Serrano Del Castillo C; Mata Serna R; Velasco Rodríguez D; López-Lorenzo JL; Llamas-Sillero P; Solán Blanco L
    Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetraploid acute promyelocytic leukemia with double translocation t (15,17) PML/RARA: the first case report in Croatia and Europe.
    Periša V; Laslo D; Franić-Šimić I; Sinčić-Petričević J
    Intractable Rare Dis Res; 2021 Feb; 10(1):48-51. PubMed ID: 33614376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro response to all-trans retinoic acid of acute promyelocytic leukemias with nonreciprocal PML/RARA or RARA/PML fusion genes.
    Mozziconacci MJ; Liberatore C; Brunel V; Grignani F; Arnoulet C; Ferrucci PF; Fernandez F; Sainty D; Pelicci PG; Birg F; Lafage-Pochitaloff M
    Genes Chromosomes Cancer; 1998 Jul; 22(3):241-50. PubMed ID: 9624536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinico-biological features and prognostic significance of PML/RARalpha isoforms in adult patients with acute promyelocytic leukemia treated with all trans retinoic acid (ATRA) and chemotherapy.
    Gupta V; Yib QL; Brandwein J; Chun K; Lipton JH; Messner H; Schuh AC; Wells RA; Minden MD; Kamel-Reidc S
    Leuk Lymphoma; 2004 Mar; 45(3):469-80. PubMed ID: 15160908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of PML-RARα is up-regulated during ATRA and arsenics combined induction without influence on long-term prognosis of acute promyelocytic leukemia.
    Zhu HH; Qin YZ; Lai YY; Shi HX; Liu YR; Jiang B; Huang XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):872-8. PubMed ID: 23998577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
    Burnett AK; Russell NH; Hills RK; Bowen D; Kell J; Knapper S; Morgan YG; Lok J; Grech A; Jones G; Khwaja A; Friis L; McMullin MF; Hunter A; Clark RE; Grimwade D;
    Lancet Oncol; 2015 Oct; 16(13):1295-305. PubMed ID: 26384238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution.
    Hu J; Shen ZX; Sun GL; Chen SJ; Wang ZY; Chen Z
    Int J Hematol; 1999 Dec; 70(4):248-60. PubMed ID: 10643151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.